Read about Dr Crichton’s epic bike ride, supporting Cancer Research UK
As the country prepares for the World Cup in Russia, Dr David Crichton is also counting down to the biggest physical challenge of his life, having already cycled the equivalent of from Doncaster to Moscow in training sessions.
Just ten months ago, the Doncaster GP signed up to take part in this year’s Deloitte Ride Across Britain and since then has clocked up over 2,200 miles on two wheels as he gears up to peak fitness.
Those energy-sapping training sessions – some up to 100 miles in a day – have resulted in David burning off a staggering 763,000 calories in the saddle as he pushes himself to his limit on his carbon road bike.
The cycle ride starts on Saturday 8 September, 2018. Over nine consecutive days, David will cycle 980 miles from Land’s End to John O’ Groats – an average of 110 a day – to raise funds for national good cause, Cancer Research UK.
En route, he will have to overcome some of the most challenging hill climbs in England, Wales and Scotland as he – and over 600 members of the amateur cycling world – make their way to the finish line on Sunday 16 September.
David, who is a GP at Bentley Surgery and Chair of NHS Doncaster Clinical Commissioning Group, says: “Cancer has touched my life, having claimed three of my four grandparents and recently affected three of my work colleagues. It will continue to affect many more people until we find a cure for this dreadful disease.
“Cancer Research UK is leading the charge to find a cure and, as a doctor with a special interest in cancer care, I know how valuable their work is. That’s why I am supporting them through the Deloitte Ride Across Britain.
“Visit my Just Giving page to donate. Even a small contribution will help bring the cure we’re all looking for a little closer. Thank you.”
Please visit: http://www.justgiving.com/fundraising/david-crichton2
Some interesting facts from Cancer Research UK:
£5 – the price of a morning coffee and breakfast muffin kits one of their ground-breaking research labs out with essential chemicals – the bread and butter of day-to-day experiments, helping to beat cancer, sooner.
£10 – the price of staying in with a film and giving up a trip to the cinema buys a new bulb for their microscopes to illuminate new ways to beat cancer, sooner. This vital bit of kit lets CRUK scientists look for crucial clues about cancer in precious samples at a fraction of the cost of a microscope!
£30 – the price of an everyday item buys plastic test tubes – the understated weaponry of cancer-fighting experiments. Basic staple lab equipment is the grease that keep the cogs of research turning – vital to our CRUK labs and to beating cancer, sooner.
£50 – staying in and cooking instead of a dinner for two in a restaurant buys a scientific sieve to separate out big bits and small bits of DNA to reveal vital clues about how to beat cancer, sooner. Tiny molecules that might play a role in cancer, but would never be seen by eye, can be identified with a machine that separates them out using electricity,
£100 – covers the cost of giving one patient the Cytosponge test and analysing their results in the lab to diagnose early stages of oesophageal cancer.
The Cytosponge is revolutionising early diagnosis for the notoriously difficult to detect oesophageal cancer by collecting cells from the gullet to look for tell-tale signs that a patient might develop the disease. Compared to an endoscopy which typically costs £400-£500 without the molecular testing of the sample in the lab, the Cytosponge is cheap and patient friendly and another example of our pioneering, ground-breaking research. This is just one example of equipment that’s helping our scientists to tackle early diagnosis.
£250 buys special chemicals, called antibodies, to light up vital, tiny parts of the cell, to shed light on new ways to beat cancer, sooner.
Imagine trying to find a needle in a haystack…then imagine if that needle was glowing fluorescent green! Antibodies can be made to recognise tumour cells. If scientists tag them with fluorescent markers, wherever we see a glow antibody we find a cancer cell!